Login

Biju Kulathakal, CEO and Co-Founder of Halo Investing, displays a sign at the office entrance stating "Impact Over Everything" to emphasize the company's core value. 00:10:00

Share On Facebook Share On Twitter

David Parker · CEO at Halo Security

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Sun Metals Corp. Expanding Promising Copper-Gold Discoveries in Northern BC
00:00:00
Patrys CEO & MD, Dr James Campbell
00:10:00
Chartright Air Group Soars with LSRA: A Success Story | Adam E. Keller, President of Chartright Air Group
00:10:00
Understanding Grand Strategy: A Historical Perspective
00:10:00
CEO Tim Buckley delivers a message from Vanguard on navigating the impact of the coronavirus.
00:10:00
Standing Out to Clients: Insights from Morgan Stanley's CMO and Facebook's VP of Global Marketing Solutions
00:10:00
where it currently exists versus Where the world is headed |Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
Interview with Jonathan Sands: Director of Sands Wealth Management on Sponsoring Project Yorkshire
00:10:00
founded companies that went public and invested in unicorns|Aaron Stachel,Partner,FirstMile Ventures
00:10:00
Redefining Financial Advisory: Beyond Investments | Alex Johnson, Founder and Financial Advisor, Oakview Wealth Management
00:10:00
Zuckerberg's Challenges: Congressional Grilling and Impact on Facebook's Stock
00:10:00
Backs bold entrepreneurs building the future that are sustain in the long run and upcoming generations|Vijay Pande,General Partner,Andreessen Horowitz

© 2026 Nehu